MICHAEL TOYE: Open Payments
NPI 1144746421 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 60 payments from 13 companies in 2025. Trend: 2023 $1,076 · 2024 $1,175 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $552 |
| PFIZER INC. | 13 | $231 |
| Axsome Therapeutics, Inc. | 4 | $203 |
| Collegium Pharmaceutical, Inc. | 10 | $148 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $81 |
| Orexo US, Inc. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Lundbeck LLC | 1 | $29 |
| Braeburn Inc. | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $20 |
Products named: QULIPTA, NURTEC ODT, Symbravo, LINZESS, XTAMPZA, JOURNAVX, Belbuca, Zubsolv.
Industry payments across WI — which companies pay providers there.
